EMA Withdrawn: Clopidogrel Acino (clopidogrel) — Acino AG

View source ↗

Summary

Clopidogrel Acino has been withdrawn from the European market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Myocardial Infarction
• Peripheral Vascular Diseases
• Stroke

Drugs mentioned

• Clopidogrel Acino (clopidogrel)

Snippet

Status: Withdrawn. Therapeutic area: Peripheral Vascular Diseases;Acute Coronary Syndrome;Myocardial Infarction;Stroke. MAH: Acino AG. Decision date: 28/01/2016